Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal-bolus vs Premixed Insulin in Hospitalized Type 2 Diabetes (PININ)
NCT02333851Phase 4Terminated
- Sponsor
- Hospital Universitario Central de Asturias
- Start
- Jun 2013
- Primary completion
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hospital Universitario Central de Asturias. Primary endpoint: Mean daily blood glucose concentration. Started Jun 2013; status: terminated.
02
Drugs
insulin glarginehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02333851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333851.